Impact of Long-Term Blood Pressure Variability on Survival Rate in Elderly Maintenance Hemodialysis Patients: A 46-Month Follow-Up Study of 245 Patients Authors: Yue Zhang, Daqing Hong, Qiang He, Guisen Li, Hui Gao Published: 2023 ABSTRACT BackgroundAt present, there are few blood pressure variability (BPV)-related studies of elderly maintenance hemodialysis (MHD) patients. This study aimed to compare the effects of long-term BPV on the 46-month survival rate of MHD patients aged <75 years and ≥75 years between 2000 and 2014, with follow-up until 2018.Material/MethodsAccording to systolic blood pressure variability (SBPV) and diastolic blood pressure variability (DBPV), patients were divided into 4 groups: a low SBPV group (n=121), a high SBPV group (n=122), a low DBPV group (n=114), and a high DBPV group (n=112).ResultsWe included 243 patients in the study. All the patients were followed up for 46 months, and 59 patients (28 males) died during follow-up. The survival rate of patients in the high SBPV group was significantly lower than that of the low SBPV group (log rank P=0.049). No significant differences were observed between the high DBPV group and low DBPV group (log rank P=0.167). There were no significant differences in survival rates between the high SBPV group and low SBPV group among patients aged <75 years (log rank P=0.656), and among patients ≥75 years, the survival rate of the high SBPV group was significantly lower than that of the low SBPV group (log rank P=0.041).ConclusionsIncreased long-term SBPV in MHD patients is associated with a decrease in long-term survival rate, and patients ≥75 years are more susceptible to it. Background Hypertension is the leading cause of cardiovascular disease and premature death worldwide [1]. Hypertension occurs in 67–92% of patients with chronic kidney disease, which increases with the decline in glomerular filtration rate (GFR) [2]. Blood pressure variability (BPV) refers to the degree of blood pressure variations within a certain period of time, representing the dynamic and characteristic physiological characteristics of cardiovascular system function [3]. It can be divided into inter-cardiac cycle BPV, short-term BPV, and long-term BPV according to the length of observation time [4]. For dialysis patients, short-term variability often refers to the blood pressure variability during dialysis, while long-term variability refers to the degree of blood pressure fluctuations at the beginning of each dialysis session within a certain period of time [5,6]. The NHANES III study suggested that long-term systolic BPV is positively associated with all-cause mortality in the general population [7], and increased long-term BPV is associated with increased cardiovascular mortality in patients with type 2 diabetes [8]. The effects of short-term BPV on the prognosis in hemodialysis patients have been extensively studied. However, the effects of long-term BPV, particularly variability over many years, have been less studied in hemodialysis patients [9,10]. Blood volume fluctuations, vascular calcification, and autonomic dysfunction in maintenance hemodialysis (MHD) patients lead to large and unstable BPV and poor prognosis [11,12]. Greater pre-dialysis BPV among hemodialysis patients was reported to be associated with all-cause mortality [13,14]. At present, there is still some controversy regarding the effects of systemic hypertension on survival in hemodialysis patients [15,16]. Therefore, this retrospective study aimed to compare the effects of long-term systemic blood pressure variability on the 46-month survival rate of 245 patients aged <75 years and ≥75 years on maintenance hemodialysis between 2000 and 2014, with follow-up until 2018. Material and Methods Ethics Statement The study was approved by the Medical Ethics Committee of Sichuan Provincial People’s Hospital (2018-167). Written informed consent was obtained from each patient. Patients Patients who entered our center for MHD due to uremia from January 2000 to January 2014 were retrospectively included. The BP data were obtained before each dialysis session of patients from January 2014 to June 2014. Inclusion criteria were patients with: (1) dialysis received for ≥3 months and (2) aged ≥18 years. Exclusion criteria were patients with: (1) BP data records for less than 1 time/month and (2) incomplete BP records. BPV measurement BP was measured using a unified electronic sphygmomanometer (OMron HEM 7200) after at least 10 min of quiet rest for each dialysis patient upon arrival at the dialysis room. BP was measured again 5 min later and the was averaged twice. BPV encompasses broad blood pressure changes that occur within seconds or minutes (very short-term BPV), over 24 h (short-term BPV), and between days (mid-term BPV) [17]. Long-term BPV were obtained from the standard deviation (SD) of BP from January 2014 to June 2014. Long-term BPV is expressed as standard deviation (SD) and was calculated by the following formula: According to systolic blood pressure variability (SBPV) and diastolic blood pressure variability (DBPV), patients were divided into 4 groups: a low SBPV group, a high SBPV group, a low DBPV group, and a high DBPV group. Follow-up observation was conducted until April 30, 2018 and the end-point was death. Statistical Analysis Statistical analyses were performed using SPSS version 17.0 (SPSS, Chicago, IL, U.S.A.). Quantitative data are described as mean±standard deviation (SD) or median (inter-quartile range). Categorical variables are presented as numbers (percentage). Normally distributed data were compared using the t test. Variables of skewed distribution were compared using the Mann-Whitney U test. Kaplan-Meier survival analysis was used to examine the mortality/survival of patients. A 2-sided P<0.05 was considered statistically significant. Results Participant Characteristics We selected 276 patients registered in the Hemodialysis Remote Terminal System of our center and who had received ≥3 months of MHD treatment. Among them, 10 patients were transferred to transplantation, 2 were transferred to peritoneal dialysis, 11 were transferred to other hospitals, and 10 cases were excluded due to incomplete registration data; the remaining 243 patients were included in the study. There were 121 cases of primary glomerular disease, 44 cases of diabetic nephropathy, 31 cases of hypertensive renal damage, 19 cases of polycystic kidney disease, and 28 cases of other primary diseases. All the patients were followed up for 46 months, and 59 patients (28 males) died during follow-up (Table 1). Survival According to the median of SBPV (12.4 mmHg) and the median of DBPV (7.2 mmHg), patients were divided into 4 groups: a low SBPV group, a high SBPV group, a low DBPV group, and a high DBPV group. Survival analysis showed that the survival rate of patients in the high SBPV group was significantly lower than that of the low SBPV group (log rank P=0.049). No significant differences were observed between the high DBPV group and low DBPV group (log rank P=0.167) (Table 1, Figure 1). There were no significant differences in survival rates between the high SBPV group and low SBPV group among patients aged <75 years (log rank P=0.656), and among patients ≥75 years, the survival rate of high SBPV group was significantly lower than that of the low SBPV group (log rank P=0.041) (Table 2, Figure 2A, 2B). There was no significant difference in survival rates between the high DBPV group and low DBPV group in patients aged <75 years (log rank P=0.875) and patients aged ≥75 years (log rank P=0.190) (Table 2, Figure 2C, 2D). Discussion In this study, we found that the survival rate of patients in the high SBPV group was significantly lower than that of the low SBPV group. Among patients ≥75 years, the survival rate of the high SBPV group was significantly lower than that of the low SBPV group. Blood pressure increase or decrease frequently occurs among patients during hemodialysis. There are currently many ways to measure BPV, including standard deviation (SD), blood pressure coefficient of variation (CV), variability independent of the mean (VIM), average real variability (ARV), and residuals [18,19]. Studies have shown that among MHD patients, patients with high BPV have higher all-cause mortality, and the prognosis of patients is consistent when SD, CV, and VIM are used for the measurement of BPV [20]. For dialysis patients, short-term variability often refers to the BPV during dialysis, while long-term variability refers to the degree of blood pressure fluctuation at the beginning of each dialysis session within a certain period of time [21]. In this study, we used 6 months of long-term BPV using SD, which takes into account the large fluctuation of blood pressure in MHD patients in the short term. The NHANES III study suggests that long-term SBPV is positively correlated with all-cause mortality in the general population [7]. SBPV before hemodialysis is an independent risk factor for cardiovascular events in dialysis patients [22,23]. The increased SBPV before hemodialysis increases the risk of cardiovascular events and all-cause death [6,24,25]. Previous studies have shown that greater pre-dialysis BPV is associated with higher mortality in hemodialysis patients [13,14]. Our research showed that in MHD patients, higher SBPV before dialysis was associated with shorter survival time and greater risk of death, and this was confirmed by a recent retrospective analysis [14]. The reason for this association may be that the mechanisms of BPV that can lead to target organ damage include endothelial response and inflammatory response, and accelerate atherosclerosis, vascular damage, and ischemic damage of target organs [26]. In addition, blood volume fluctuations are more pronounced in MHD patients, combined with vascular calcification and autonomic dysfunction, which lead to greater BPV, which is associated with poor prognosis [11,12]. At present, the global population is gradually aging. Studies have shown that elevated SBPV in elderly patients is often associated with high rates of cardiovascular events and all-cause mortality [27], while in China, elderly patients often have elevated SBPV [28]. Wang et al found that pre-dialysis SBP was significantly associated with all-cause mortality and cardio-cerebrovascular deaths in patients aged 60–80 years [29]. In the present study, MHD patients were divided into an advanced age group (≥75 years) and a non-advanced age group (<75 years). We found no significant differences in survival rates between the high SBPV group and low SBPV group among patients aged <75 years and patients ≥75 years, and the survival rate of the high SBPV group was significantly lower than that of the low SBPV group. There was no significant difference in survival rates between the high DBPV group and low DBPV group in patients aged <75 years and patients aged ≥75 years. We speculated this is because the patients aged ≥75 years with MHD may have significant vascular calcification, worse cardiovascular function, and were more likely to be affected by blood pressure fluctuations. Limitations of the Study The small sample size and short study duration are limitations of this study. Therefore, a multicenter, prospective clinical study with a large sample size and long-term follow-up is needed. Conclusions In conclusion, increased long-term SBPV in MHD patients is associated with a decrease in long-term survival rate, and patients ≥75 years are more susceptible to it.